Download PDF
Klin Monbl Augenheilkd 2022; 239(09): 1111-1118
DOI: 10.1055/a-1797-5188
Übersicht

Sekundärglaukome im Rahmen retinaler Erkrankungen

Article in several languages: deutsch | English
Roman Greslechner
Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum Regensburg, Deutschland
,
Horst Helbig
Klinik und Poliklinik für Augenheilkunde, Universitätsklinikum Regensburg, Deutschland
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Zusammenfassung

Eine Vielzahl retinaler Erkrankungen kann zur Entwicklung eines Glaukoms führen. Die häufigste Form dieser Sekundärglaukome sind die Neovaskularisationsglaukome, die den Hauptteil dieser Übersicht bilden. Dabei handelt sich um ein schwerwiegendes Krankheitsbild, das in mehreren Stadien verläuft, wobei die Prognose mit zunehmendem Stadium ungünstiger und die Therapie herausfordernder wird. Neben Pathogenese und Diagnostik wird daher ein Schwerpunkt auf die Früherkennung und eine an das jeweilige Krankheitsstadium angepasste Therapie gelegt. Auch seltenere Sekundärglaukome im Rahmen intraokularer Tumoren sowie Glaukome assoziiert mit einer Netzhautablösung (Schwartz-Matsuo-Syndrom) und Glaukome, die im Spätverlauf nach unkomplizierter Vitrektomie auftreten, werden in dieser Übersicht diskutiert.

Schlüsselwörter

Sekundärglaukom - Neovaskularisationsglaukom - diabetische Retinopathie - Zentralvenenverschluss - Schwartz-Matsuo-Syndrom - Therapie


Publication History

Received: 01 March 2022

Accepted: 08 March 2022

Accepted Manuscript online:
14 March 2022

Article published online:
17 May 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References/Literatur

  • 1 Moshfeghi DM, Moshfeghi AA, Finger PT. Enucleation. Surv Ophthalmol 2000; 44: 277-301
    CrossrefPubMedSearch in Google Scholar
  • 2 Setlur VJ, Parikh JG, Rao NA. Changing causes of enucleation over the past 60 years. Graefes Arch Clin Exp Ophthalmol 2010; 248: 593-597
    CrossrefPubMedSearch in Google Scholar
  • 3 Gong H, Ren J, Zheng B. et al. The profile of secondary glaucoma in China: a study of over 10,000 patients. J Glaucoma 2021; 30: 895-901
    CrossrefPubMedSearch in Google Scholar
  • 4 Dubey S, Jain K, Mukherjee S. et al. Current profile of secondary glaucoma in a Northern India tertiary eye care hospital. Ophthalmic Epidemiol 2019; 26: 1-8
    CrossrefPubMedSearch in Google Scholar
  • 5 Lin PA, Lee CY, Huang FC. et al. Trend of neovascular glaucoma in Taiwan: a 15-year nationwide population-based cohort study. Ophthalmic Epidemiol 2020; 27: 390-398
    CrossrefPubMedSearch in Google Scholar
  • 6 Baseline and Early Natural History Report. The Central Vein Occlusion Study. Arch Ophthalmol 1993; 111: 1087-1095
    CrossrefPubMedSearch in Google Scholar
  • 7 Tasman W, Magargal LE, Augsburger JJ. Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization. Ophthalmology 1980; 87: 400-402
    CrossrefPubMedSearch in Google Scholar
  • 8 Damji KF, Konstas AGP, Liebmann JM. et al. Intraocular pressure following phacoemulsification in patients with and without exfoliation syndrome: a 2 year prospective study. Br J Ophthalmol 2006; 90: 1014
    CrossrefPubMedSearch in Google Scholar
  • 9 Armaly MF, Baloglou PJ. Diabetes Mellitus and the Eye: I. Changes in the Anterior Segment. Arch Ophthalmol 1967; 77: 485-492
    CrossrefPubMedSearch in Google Scholar
  • 10 Madsen PH. Haemorrhagic glaucoma. Comparative study in diabetic and nondiabetic patients. Br J Ophthalmol 1971; 55: 444-450
    CrossrefPubMedSearch in Google Scholar
  • 11 Ohrt V. The frequency of rubeosis iridis in diabetic patients. Acta Ophthalmol (Copenh) 1971; 49: 301-307
    CrossrefPubMedSearch in Google Scholar
  • 12 Nielsen NV. The prevanlence of glaucoma and ocular hypertension in type 1 and 2 diabetes mellitus. An epidemiological study of diabetes mellitus on the island of Falster, Denmark. Acta Ophthalmol (Copenh) 1983; 61: 662-672
    CrossrefPubMedSearch in Google Scholar
  • 13 Rudkin AK, Lee AW, Chen CS. Ocular neovascularization following central retinal artery occlusion: prevalence and timing of onset. Eur J Ophthalmol 2010; 20: 1042-1046
    CrossrefPubMedSearch in Google Scholar
  • 14 Browning DJ, Scott AQ, Peterson CB. et al. The risk of missing angle neovascularization by omitting screening gonioscopy in acute central retinal vein occlusion. Ophthalmology 1998; 105: 776-784
    CrossrefPubMedSearch in Google Scholar
  • 15 Blinder KJ, Friedman SM, Mames RN. Diabetic iris neovascularization. Am J Ophthalmol 1995; 120: 393-395
    CrossrefPubMedSearch in Google Scholar
  • 16 Neupert JR, Brubaker RF, Kearns TP. et al. Rapid resolution of venous stasis retinopathy after carotid endarterectomy. Am J Ophthalmol 1976; 81: 600-602
    CrossrefPubMedSearch in Google Scholar
  • 17 Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic syndrome – a systematic review. Med Sci Monit 2012; 18: RA138-RA144
    CrossrefPubMedSearch in Google Scholar
  • 18 Wand M, Dueker DK, Aiello LM. et al. Effects of panretinal photocoagulation on rubeosis iridis, angle neovascularization, and neovascular glaucoma. Am J Ophthalmol 1978; 86: 332-339
    CrossrefPubMedSearch in Google Scholar
  • 19 Little HL, Rosenthal AR, Dellaporta A. et al. The effect of pan-retinal photocoagulation on rubeosis iridis. Am J Ophthalmol 1976; 81: 804-809
    CrossrefPubMedSearch in Google Scholar
  • 20 Laatikainen L, Kohner EM, Khoury D. et al. Panretinal photocoagulation in central retinal vein occlusion: A randomised controlled clinical study. Br J Ophthalmol 1977; 61: 741-753
    CrossrefPubMedSearch in Google Scholar
  • 21 Laatikainen L. Preliminary report on effect of retinal panphotocoagulation on rubeosis iridis and neovascular glaucoma. Br J Ophthalmol 1977; 61: 278-284
    CrossrefPubMedSearch in Google Scholar
  • 22 Jacobson DR, Murphy RP, Rosenthal AR. The treatment of angle neovascularization with panretinal photocoagulation. Ophthalmology 1979; 86: 1270-1275
    CrossrefPubMedSearch in Google Scholar
  • 23 Murphy RP, Egbert PR. Regression of iris neovascularization following panretinal photocoagulation. Arch Ophthalmol 1979; 97: 700-702
    CrossrefPubMedSearch in Google Scholar
  • 24 Pavan PR, Folk JC, Weingeist TA. et al. Diabetic rubeosis and panretinal photocoagulation: a prospective, controlled, masked trial using iris fluorescein angiography. Arch Ophthalmol 1983; 101: 882-884
    CrossrefPubMedSearch in Google Scholar
  • 25 Magargal LE, Brown GC, Augsburger JJ. et al. Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction. Ophthalmology 1982; 89: 780-784
    CrossrefPubMedSearch in Google Scholar
  • 26 Kaufman SC, Ferris FL, Swartz M. Intraocular pressure following panretinal photocoagulation for diabetic retinopathy: diabetic retinopathy report no. 11. Arch Ophthalmol 1987; 105: 807-809
    CrossrefPubMedSearch in Google Scholar
  • 27 Ohnishi Y, Ishibashi T, Sagawa T. Fluorescein gonioangiography in diabetic neovascularisation. Graefes Arch Clin Exp Ophthalmol 1994; 232: 199-204
    CrossrefPubMedSearch in Google Scholar
  • 28 Horsley MB, Kahook MY. Anti-VEGF therapy for glaucoma. Curr Opin Ophthalmol 2010; 21: 112-117
    CrossrefPubMedSearch in Google Scholar
  • 29 Yazdani S, Hendi K, Pakravan M. et al. Intravitreal bevacizumab for neovascular glaucoma. J Glaucoma 2009; 18: 632-637
    CrossrefPubMedSearch in Google Scholar
  • 30 Wakabayashi T, Oshima Y, Sakaguchi H. et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology 2008; 115: 1571-1580.e1–e3
    CrossrefPubMedSearch in Google Scholar
  • 31 European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition. Br J Ophthalmol 2021; 105 (Suppl. 01) S1-S169
    CrossrefPubMedSearch in Google Scholar
  • 32 Takihara Y, Inatani M, Fukushima M. et al. Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Am J Ophthalmol 2009; 147: 912-918 918.e1
    CrossrefPubMedSearch in Google Scholar
  • 33 Shen CC, Salim S, Du H. et al. Trabeculectomy versus Ahmed Glaucoma Valve implantation in neovascular glaucoma. Clin Ophthalmol 2011; 5: 281-286
    CrossrefPubMedSearch in Google Scholar
  • 34 Tsai JC, Bloom PA, Franks WA. et al. Combined transscleral diode laser cyclophotocoagulation and transscleral retinal photocoagulation for refractory neovascular glaucoma. Retina 1996; 16: 164-165
    CrossrefPubMedSearch in Google Scholar
  • 35 Bloom PA, Tsai JC, Sharma K. et al. “Cyclodiode” Trans-scleral diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma. Ophthalmology 1997; 104: 1508-1520
    CrossrefPubMedSearch in Google Scholar
  • 36 Ghosh S, Singh D, Ruddle JB. et al. Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma. Clin Exp Ophthalmol 2010; 38: 353-357
    CrossrefPubMedSearch in Google Scholar
  • 37 Iliev ME, Gerber S. Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 2007; 91: 1631-1635
    CrossrefPubMedSearch in Google Scholar
  • 38 Murphy CC, Burnett CAM, Spry PGD. et al. A two centre study of the dose-response relation for transscleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 2003; 87: 1252
    CrossrefPubMedSearch in Google Scholar
  • 39 Yildirim N, Yalvac IS, Sahin A. et al. A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma valve implant in neovascular glaucoma. J Glaucoma 2009; 18: 192-196
    CrossrefPubMedSearch in Google Scholar
  • 40 Strzalkowski P, Strzalkowska A, Göbel W. et al. Combined vitrectomy, near-confluent panretinal endolaser, bevacizumab and cyclophotocoagulation for neovascular glaucoma – a retrospective interventional case series. F1000Res 2020; 9: 1236
    CrossrefPubMedSearch in Google Scholar
  • 41 Camp DA, Yadav P, Dalvin LA. et al. Glaucoma secondary to intraocular tumors: mechanisms and management. Curr Opin Ophthalmol 2019; 30: 71-81
    CrossrefPubMedSearch in Google Scholar
  • 42 de Leon JM, Walton DS, Latina MA. et al. Glaucoma in retinoblastoma. Semin Ophthalmol 2009; 20: 217-222
    CrossrefPubMedSearch in Google Scholar
  • 43 Vempuluru VS, Jakati S, Krishnamurthy R. et al. Glaucoma as the presenting sign of intraocular tumors: beware of the masquerading sign. Int Ophthalmol 2020; 40: 1789-1795
    CrossrefPubMedSearch in Google Scholar
  • 44 Pereira PR, Odashiro AN, Filho JPS. et al. Malignancy in the blind painful eye – report of two cases and literature review. Diagn Pathol 2006; 1: 45
    CrossrefPubMedSearch in Google Scholar
  • 45 Girkin CA, Goldberg I, Mansberger SL. et al. management of iris melanoma with secondary glaucoma. J Glaucoma 2002; 11: 71-74
    CrossrefPubMedSearch in Google Scholar
  • 46 Etheridge T, Larson JC, Nork TM. et al. Schwartz-Matsuo syndrome: An important cause of secondary glaucoma. Am J Ophthalmol Case Rep 2020; 17: 100586
    CrossrefPubMedSearch in Google Scholar
  • 47 Chang S. LXII Edward Jackson lecture: open angle glaucoma after vitrectomy. Am J Ophthalmol 2006; 141: 1033-1043
    CrossrefPubMedSearch in Google Scholar
  • 48 Koreen L, Yoshida N, Escariao P. et al. Incidence of, risk factors for, and combined mechanism of late-onset open-angle glaucoma after vitrectomy. Retina 2012; 32: 160-167
    CrossrefPubMedSearch in Google Scholar